Simon Lo


Dr. Simon Lo is Professor and Vice Chair of Strategic Planning at the University of Washington Department of Radiation Oncology and also Professor of Neurological Surgery. Dr. Lo has edited 4 comprehensive textbooks in SRS/ SBRT in addition to a comprehensive textbook in Adult CNS Oncology and has published over 200 full peer-reviewed papers, a majority of which center on SRS/ SBRT for all body sites and has led the SBRT programs in 3 NCI-designated Comprehensive Cancer Centers. Dr. Lo is currently the President of the Radiation Oncology Chapter of American College of Radiology, a member of the Board of Directors Radiosurgery Society. He is  a Fellow of American College of Radiology (FACR) and ASTRO (FASTRO).



Stereotactic radiosurgery (SRS)/ stereotactic radiotherapy (SRT) has become one of the standard treatment options for patients with limited brain metastases. Controversies exist regarding the best  strategy to incorporate both surgery and SRS/ SRT in patients with large brain metastases. SRS/ SRT alone, after surgical resection or before surgical resection have been used to manage patients with large brain metastases. This lecture will cover the pros and cons and the outcomes with each strategy.

Share This Speaker
Speaker Details
  • Location
  • Affiliations of the Speaker
    University of Washington School of Medicine
SBRT for spine metastasis - the current state of affairs and future directions

8th November 2020,13:00pm

Events of the Speaker
You might also love these events.
November 7, 2020
The highlights for the 7th HKIOS include application of artificial intelligence in radiotherapy planning and biomarkers discovery, ultra-high dose rate (FLASH) radiotherapy and alternating electric fields (tumour treating fields or TTF). Many oncologists are not familiar with these brand-new modalities, which are being slowly incorporated into our clinical practice. Due to Covid-19 pandemic, we shall conduct our symposium virtually. We thank our local and overseas speakers for their stern support and contribution again.
October 26, 2019
The 6th Hong Kong International Oncology Symposium (6th HKIOS) was conducted in Sheraton Hong Kong Hotel & Towers on 26th and 27th October. The event was joined by renowned speakers with a higher international representation, reflecting our initiatives in fostering international medical collaborations. Some emerging topics such as artificial intelligence, immunotherapy and radiotherapy were discussed in the symposium.